These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 15156433)

  • 21. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
    AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials.
    Blanc FX; Havlir DV; Onyebujoh PC; Thim S; Goldfeld AE; Delfraissy JF
    J Infect Dis; 2007 Aug; 196 Suppl 1():S46-51. PubMed ID: 17624825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin.
    Manosuthi W; Sungkanuparph S; Thakkinstian A; Rattanasiri S; Chaovavanich A; Prasithsirikul W; Likanonsakul S; Ruxrungtham K
    Clin Infect Dis; 2006 Jul; 43(2):253-5. PubMed ID: 16779754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Directly observed therapy (DOT) for individuals with HIV: successes and challenges.
    Mitty JA; Macalino G; Taylor L; Harwell JI; Flanigan TP
    MedGenMed; 2003 Feb; 5(1):30. PubMed ID: 12827091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of antituberculosis treatment on virological response to highly active antiretroviral therapy: implications for resource-limited settings?
    Lawn SD; Wood R
    J Infect Dis; 2006 Nov; 194(10):1467-8; author reply 1468. PubMed ID: 17054078
    [No Abstract]   [Full Text] [Related]  

  • 26. Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential.
    Harries AD; Hargreaves NJ; Chimzizi R; Salaniponi FM
    Bull World Health Organ; 2002; 80(6):464-9. PubMed ID: 12132003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tuberculosis and HIV co-infection: a therapeutic challenge].
    Charbonnier F; Calmy A; Janssens JP
    Rev Med Suisse; 2011 Nov; 7(318):2295-6, 2298-300. PubMed ID: 22400365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tuberculosis and HIV coinfection in three patients: the possibilities for simultaneous treatment].
    van Oosterhout JJ; Boeree MJ; Burger DM; de Lange WC; van Crevel R; Koopmans PP
    Ned Tijdschr Geneeskd; 2003 Mar; 147(9):369-72. PubMed ID: 12661452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Managements of tuberculosis complicated with HIV infection and AIDS].
    Xiao H; He G
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Nov; 23(11):659-62. PubMed ID: 11225028
    [No Abstract]   [Full Text] [Related]  

  • 30. Issues in the management of HIV-related tuberculosis.
    Burman WJ
    Clin Chest Med; 2005 Jun; 26(2):283-94, vi-vii. PubMed ID: 15837111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in CD 4 counts in HIV positive patients treated with HAART and antitubercular drugs: an observational study from North India.
    Sharma A; Wanchu A; Bansal V; Singh S; Varma S
    Indian J Pathol Microbiol; 2007 Oct; 50(4):905-7. PubMed ID: 18306602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.
    Dheda K; Lampe FC; Johnson MA; Lipman MC
    J Infect Dis; 2004 Nov; 190(9):1670-6. PubMed ID: 15478074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy).
    Farmer P; Léandre F; Mukherjee J; Gupta R; Tarter L; Kim JY
    Bull World Health Organ; 2001; 79(12):1145-51. PubMed ID: 11799447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources.
    Colebunders R; John L; Huyst V; Kambugu A; Scano F; Lynen L
    Int J Tuberc Lung Dis; 2006 Sep; 10(9):946-53. PubMed ID: 16964782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Practice guideline prevention, diagnosis and treatment of tuberculosis in patients with an HIV infection].
    van Leth F; Gebhart AC; van Altena R; Rijkeboer AA; Reusken AM; van Gerven PJ;
    Ned Tijdschr Geneeskd; 2009; 153():A1225. PubMed ID: 20482917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune reconstitution syndrome following initiation of antiretroviral therapy in a patient with HIV infection and multidrug-resistant tuberculosis.
    Swaminathan S; Padmapriyadarsini C; Narendran G; Thomas BE; Anand S; Rajyalakshmi A
    Indian J Chest Dis Allied Sci; 2005; 47(4):299-304. PubMed ID: 16255403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.
    van Oosterhout JJ; Kumwenda JJ; Beadsworth M; Mateyu G; Longwe T; Burger DM; Zijlstra EE
    Antivir Ther; 2007; 12(4):515-21. PubMed ID: 17668560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda.
    Kent DM; McGrath D; Ioannidis JP; Bennish ML
    Clin Infect Dis; 2003 Jul; 37(Suppl 1):S13-24. PubMed ID: 12822128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs for tuberculosis.
    Treat Guidel Med Lett; 2007 Mar; 5(55):15-22. PubMed ID: 17325626
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV-associated tuberculosis: clinical update.
    Swaminathan S; Padmapriyadarsini C; Narendran G
    Clin Infect Dis; 2010 May; 50(10):1377-86. PubMed ID: 20388036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.